Clinical trial referral management covers the operational work that follows a referral, including intake, permitted follow-up, preliminary information collection, handoff, and pathway tracking. The seven practices in this article provide a framework for making that work more visible, repeatable, and measurable. Their effect on enrollment outcomes depends on the study and should be evaluated against the site’s own data.
Referral management covers operational work after a candidate has been identified or referred, including intake processing, permitted follow-up, preliminary prescreening, site handoff, and progression tracking. It is distinct from candidate generation, which governs how potential participants are identified or sourced.
Defined referral-management practices can make ownership, status, follow-up, handoffs, and stage-level measurement easier to review. They create a clearer operating record, but they do not by themselves determine conversion or make enrollment predictable.
For the foundational understanding of what the referral-to-randomization pathway includes and how conversion is measured, see what is referral to randomization. For the structured workflow framework within which these best practices operate, see referral-to-randomization workflow. For the follow-up protocol design that practice seven depends on, see referral follow-up workflows for clinical trials.
Each practice below addresses a specific operational gap in the referral management lifecycle. They are listed in roughly chronological order within the referral-to-randomization pathway.
Define the information a referral record should contain before it advances within the site-approved workflow. That may include contact information, source attribution, study-interest details, communication permissions, and candidate-reported preliminary information requested by the site. A clear data standard can make missing information easier to identify before authorized site review.
A referral response-time standard defines the site’s expected interval between referral receipt and first documented action or contact attempt. The standard should reflect the study, staffing, communication permissions, and local workflow. Sites can compare adherence with their own progression and disposition data to determine whether response timing deserves further review.
The research site defines the site-approved preliminary question set, conversation structure, documentation fields, routing instructions, and escalation rules used before authorized site review. The workflow should collect and document candidate-reported responses consistently without assigning formal screening or eligibility decisions to the preliminary prescreening function.
The site handoff package organizes the information the site expects to receive from the preliminary workflow. The handoff standard can define which candidate-reported responses, unresolved items, contact history, routing status, and scheduling context should be documented before transfer to authorized site personnel.
Stage-specific metrics can show where volume, status, or elapsed time changes across the pathway. Depending on the study, a site may track intake-to-preliminary-review progression, preliminary workflow completion, time to site review, site-controlled screening outcomes, and later-stage progression. These measures help narrow the investigation but do not establish cause by themselves.
A structured follow-up protocol defines permitted contact attempts, timing, channels, escalation, documentation, and closure criteria for non-responsive referrals. Without a defined process, follow-up depends more heavily on individual discretion and is harder to execute and measure consistently.
Referral sources can differ in volume, contactability, progression, and downstream site-controlled outcomes. Tracking source-level patterns helps a site identify questions worth reviewing. A source with lower downstream progression is not automatically a poor source; results may also reflect population, geography, protocol requirements, site process, or other factors.
Structured referral management can change how much administrative reconstruction, follow-up, and documentation work reaches the coordinator team. When local workload data shows that these activities are consuming coordinator time, a site can compare the current model with a more clearly separated intake and preliminary-prescreening workflow and measure whether the change affects workload.
Any downstream effect should be measured rather than assumed. Changes in referral conversion, coordinator workload, site-controlled screening outcomes, or later progression may have multiple contributors. For guidance on reviewing coordinator workload specifically, see how to reduce coordinator burden. The intake and preliminary-prescreening foundations of these practices are detailed at clinical trial intake and clinical trial prescreening. For source-level measurement, see referral source performance tracking.
Common questions about clinical trial referral management practices and how they can be applied and measured.
Related Resources
Continue Reading
If your site wants to review how referrals move through the current workflow, a structured conversation can help compare ownership, follow-up, preliminary prescreening, handoff, and measurement practices without assuming where the main issue sits.